Doug Katz

Dolphins fanatic, not the fish, although I really like them too. Knicks, Mets, Camp Guy - not necessarily in that order. Jersey Boy, Boston U - Phins Up!

[TG Therapeutics @TGTherapeutics]

#BreakingNews - $TGTX announces initiation of a Phase 2 clinical trial evaluating our therapy for #RMS in adults with treatment-resistant schizophrenia - Details: https://t.co/yyeTkt6RIK #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

This #MSAwarenessWeek, March 8-14, TG stands with everyone living with #MS and #RMS. And in support of the @MSSociety 2026 campaign, we recognize the challenges that are often #MSUnseen and remain committed to advancing science and improving outcomes. #FearlessForPatients $TGTX

[TG Therapeutics @TGTherapeutics]

TG is proud to collaborate with actress and MS advocate Christina Applegate to help elevate patient voices and support meaningful conversations in multiple sclerosis! Learn more about our newly launched platform https://t.co/wayVwiII4g Details: https://t.co/r4Zv8PIaQX #NextinMS $TGTX

[TG Therapeutics @TGTherapeutics]

#SaveTheDate – TG’s CEO Mike Weiss will present at the 44th Annual J.P.Morgan Healthcare Conference in San Francisco next Tues., Jan. 13th @ 1:30PM PST/4:30PM ET. Details: https://t.co/VOkg7HBVHF Live webcast at: https://t.co/5RNBBuGxFN #JPM26 #FearlessForPatients $TGTX

[TG Therapeutics @TGTherapeutics]

#JoinUs #Today for the Fireside Chat with TG's CEO Mike Weiss at the 8th Annual Evercore Healthcare Conference at 12:30pm ET - Dec. 2nd. Webcast at: https://t.co/7lkMzvM84h $TGTX #MS #Evercore #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

$TGTX shared 3 presentations today @ #ECTRIMS2025 including new data showing approximately 90% of RMS patients are free from disability progression after 6 yrs on therapy! Learn more: https://t.co/dGbNC1KMeJ - Visit our TG/Neuraxpharm Booth A04 for #BOOTHTALKS 9/25 10:55 & 13:00 CEST

[TG Therapeutics @TGTherapeutics]

Abstracts are Live! #ECTRIMS2025 Barcelona, Spain Sept. 24-26. $TGTX will share 3 presentations highlighting data in #RMS. Abstracts & Learn More: https://t.co/If8NcQAjCl - Please visit our TG Booth A04 and our TG/NRX Business Lounge on Level 2 #MS #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

$TGTX Q1 2025 Financial Results have been released! Details: https://t.co/X7hFKBRBPz - Join our #Earnings call this morning, May 5th at 8:30AM ET. Dial in: 1-877-407-8029 (US), 1-201-689-8029 (Ex-US) Title: TG Q1 2025 – Webcast at: https://t.co/5RNBBuFZQf #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

TG shared two presentations yesterday at #AANAM San Diego 2025, highlighting additional data from our TG trials in #RMS. Learn More: https://t.co/F8g2XOv2O0 – Thank you to everyone for visiting our TG Booth & Business Suite - #FearlessForPatients @AANmember $TGTX

[TG Therapeutics @TGTherapeutics]

TG has shared presentations today at #ACTRIMS25 highlighting data from the ULTIMATE I & II Ph 3 trials and the ENHANCE Ph 3b trial in #RMS. Details: https://t.co/BmBi7Jhq8c Visit our $TGTX Business Suite in the exhibit hall if attending! #FearlessForScience #ACTRIMSForum

[TG Therapeutics @TGTherapeutics]

Today, our CEO Mike Weiss is being honored by the National MS Society as their 2025 Hope Award recipient. $TGTX is a proud sponsor of the NMSS and all they do for the MS community. Thank you to all who participated in raising funds for the @MSSociety. #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

#Milestones – TG Therapeutics announced preliminary 4th quarter and full year 2024 net BRIUMVI revenue (unaudited), as well as our anticipated development milestones for 2025! Check out the press release here: https://t.co/EaO3eDzflc #FearlessForPatients $TGTX #Strategy2025

[TG Therapeutics @TGTherapeutics]

#Reminder – In 30 minutes TG CEO Mike Weiss will be presenting at the 43rd Annual J.P.Morgan Healthcare Conference! Live Webcast at: https://t.co/5RNBBuGxFN #JPM25 #FearlessForPatients $TGTX

[TG Therapeutics @TGTherapeutics]

#WatchToday – TG CEO Mike Weiss will be presenting today at the 43rd Annual J.P.Morgan Healthcare Conference - Mon, Jan. 13th @ 4:30pm PT/7:30pm ET.  Live Webcast at: https://t.co/5RNBBuGxFN  #JPM25 #FearlessForPatients $TGTX

[TG Therapeutics @TGTherapeutics]

#SaveTheDate - TG CEO Mike Weiss will present at the 43rd Annual J.P.Morgan Healthcare Conference next week. Live webcast Mon., Jan. 13th @ 4:30PM PT/7:30PM ET. Details: https://t.co/16j7eBzv17 Webcast at: https://t.co/5RNBBuFZQf #JPM25 #FearlessForPatients $TGTX

[TG Therapeutics @TGTherapeutics]

The TG family wishes all of our patients, health care providers, partners and you and your family a very happy and healthy New Year. Cheers to 2025! $TGTX #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

#Today - Join the Fireside Chat with TG's CEO Mike Weiss during the 7th Annual Evercore HealthCONx Conference at 10:00am ET today, Dec. 3rd. Webcast at: https://t.co/7lkMzvLAeJ $TGTX #MS #Evercore #FearlessForPatients

[TG Therapeutics @TGTherapeutics]

#SaveTheDate - Join our CEO Mike Weiss for a Fireside Chat during the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3rd at 10:00am ET.  Webcast at: https://t.co/7lkMzvM84h $TGTX #Evercore #FearlessForPatients